Sarepta Therapeutics, Inc.SRPTNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+25.4%
5Y CAGR+21.3%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+25.4%/yr
vs +22.9%/yr prior
5Y CAGR
+21.3%/yr
Recent acceleration
Acceleration
+2.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.6x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$2.90B+72.1%
2024$1.68B+11.4%
2023$1.51B+2.9%
2022$1.47B+26.5%
2021$1.16B+5.2%
2020$1.10B+1.6%
2019$1.09B+68.5%
2018$644.66M+116.5%
2017$297.80M+9.4%
2016$272.15M-